| Application no. and date | 15865213.1 (espacenet) (Federated) (European Patent Register), 20151203 | | Patent/reg. no. and date | DK/EP 3227675, 20230315 | | Publication date | 20171011 | | Priority no. and date | US 201462086977 P, 20141203, US 201462088478 P, 20141205, US 201562153872 P, 20150428, US 201562173782 P, 20150610, US 201562218728 P, 20150915 | | EP pub. no. and date |
EP 3227675 20171011 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US,
Acceleron Pharma Inc., 128 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | P82084DK01 | | Inventor | ATTIE, Kenneth M., 228 Marlborough Street
Boston, MA 02116, US,
ROVALDI, Christopher, 24 Orchard Road
Swampscott, MA 01907, US,
LAADEM, Abderrahmane, 12 Matthews Farm Road
Belle Mead, NJ 08502, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 35/02 (2006.01) , A61P 43/00 (2006.01) , A61P 7/00 (2006.01) , A61P 7/06 (2006.01) , C07K 14/71 (2006.01) , G01N 33/49 (2006.01) | | Title | ACTIVIN-ACTRII-ANTAGONISTER OG ANVENDELSER TIL BEHANDLING AF MYELODYSPLASTISK SYNDROM | | Int. application no. | US2015063595 | | Int. publication no. | WO2016090077 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
